The BioPharm International Editorial Advisory Board shares their professional expertise in bioprocessing topics to help shape editorial content and review peer-review papers.
The following biopharma industry experts serve as members of the BioPharm International Editorial Advisory Board.
K. A. Ajit-Simh, President, Shiba Associates
Madhavan Buddha, Freelance Consultant
Rory Budihandojo, Independent Consultant
Suggy S. Chrai, President and CEO, The Chrai Associates
Uwe Gottschalk, Vice-President, Chief Technology Officer, Pharma/Biotech, Lonza AG
Fiona M. Greer, Senior Consultant, BioPharmaSpec (UK)
Rajesh K. Gupta, Vaccinnologist and Microbiologist
Denny Kraichely, Department Head, Analytical Project Leadership, Merck Vaccines
Stephan O. Krause, Head of Product Quality Group, AstraZeneca Biologics
Steven S. Kuwahara, Principal Consultant, GXP BioTechnology LLC
Eric S. Langer, President and Managing Partner, BioPlan Associates, Inc.
Howard L. Levine, Senior Managing Director, BDO, National Leader, BioProcess Technology Group
Hank Liu, Head of Quality Control, Sanofi Pasteur
Herb Lutz, Principal Consulting Engineer, Merck Millipore
Hanns-Christian Mahler, Head Drug Product Services, Lonza AG
Jerold Martin, Independent Consultant
Hans-Peter Meyer, Lecturer, University of Applied Sciences and Arts Western Switzerland, Institute of Life Technologies
K. John Morrow, President, Newport Biotech
David Radspinner, VP/GM Global Commercial Transition, Cytiva
Tom Ransohoff, COO, 4th Dimension Bioprocess
Anurag Rathore, Biotech CMC Consultant, Faculty Member, Indian Institute of Technology
Susan J. Schniepp, Executive Vice President of Post-Approval Pharma and Distinguished Fellow, Regulatory Compliance Associates, Inc.
Tim Schofield, Consultant, CMC Sciences, LLC
Paula Shadle, Principal Consultant, Shadle Consulting
Thomas J. Vanden Boom, Independent Biotechnology Consultant